Ethic Inc. decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 8.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,164 shares of the semiconductor company's stock after selling 1,446 shares during the period. Ethic Inc.'s holdings in Synopsys were worth $6,611,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in SNPS. Cornerstone Planning Group LLC raised its position in Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 44 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after buying an additional 53 shares during the period. Ameriflex Group Inc. purchased a new position in shares of Synopsys in the fourth quarter worth about $29,000. Cloud Capital Management LLC purchased a new position in shares of Synopsys in the first quarter worth about $36,000. Finally, Meeder Asset Management Inc. increased its holdings in shares of Synopsys by 33.3% in the first quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock worth $45,000 after buying an additional 26 shares during the period. Hedge funds and other institutional investors own 85.47% of the company's stock.
Analyst Ratings Changes
Several research analysts have recently commented on SNPS shares. Piper Sandler lifted their price objective on Synopsys from $615.00 to $660.00 and gave the stock an "overweight" rating in a report on Monday, July 21st. Stifel Nicolaus set a $550.00 price target on Synopsys in a research report on Monday, April 28th. Rosenblatt Securities boosted their price target on Synopsys from $625.00 to $650.00 and gave the stock a "buy" rating in a research report on Friday, July 25th. KeyCorp boosted their price target on Synopsys from $540.00 to $610.00 and gave the stock an "overweight" rating in a research report on Thursday, July 10th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $660.00 price target (up from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. Thirteen research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $630.67.
Get Our Latest Stock Analysis on Synopsys
Insider Activity at Synopsys
In related news, CRO Richard S. Mahoney sold 9,010 shares of the stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the transaction, the executive owned 1,485 shares of the company's stock, valued at approximately $699,746.85. This trade represents a 85.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the completion of the transaction, the chief executive officer directly owned 71,589 shares of the company's stock, valued at approximately $32,782,750.77. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,686 shares of company stock valued at $13,001,048. Insiders own 0.62% of the company's stock.
Synopsys Price Performance
Synopsys stock traded down $12.54 during mid-day trading on Tuesday, hitting $612.79. The stock had a trading volume of 1,170,182 shares, compared to its average volume of 1,424,596. The firm has a market capitalization of $95.08 billion, a P/E ratio of 44.24, a P/E/G ratio of 4.09 and a beta of 1.15. The company has a current ratio of 7.02, a quick ratio of 6.85 and a debt-to-equity ratio of 1.01. The firm's 50 day moving average is $561.49 and its 200 day moving average is $498.35. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter in the prior year, the firm posted $3.00 EPS. Synopsys's quarterly revenue was up 10.3% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. On average, sell-side analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.